December 6, 2002
Novo Nordisk Has Recalled Novolin
The Food and Drug
Administration (FDA) has released the following information.
Novolin 70/30 InnoLet, 70% NPH, Human Insulin Isophane Suspension and 30%
Insulin Injection (rDNA origin), 100 units/mL, 3mL Prefilled Insulin
Syringes, Novo Nordisk.
Recall # D-062-3.
Lot # MS 60812 Exp. 6/2004
Recalling Firm: Novo Nordisk Pharmaceuticals, Princeton, NJ, by fax on
August 16, 2002.
Manufacturer: Novo Nordisk A/S Bagsvaerd, Denmark. Firm initiated recall is
Defective container; delivery system may dispense less than the expected
amount of insulin
VOLUME OF PRODUCT IN COMMERCE
Nationwide and Puerto Rico.